MACKAY, ANDREW REAY
 Distribuzione geografica
Continente #
NA - Nord America 3.121
EU - Europa 1.744
AS - Asia 1.107
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
AF - Africa 4
Totale 6.005
Nazione #
US - Stati Uniti d'America 3.116
IE - Irlanda 617
CN - Cina 459
SG - Singapore 292
TR - Turchia 289
IT - Italia 228
DE - Germania 216
SE - Svezia 169
UA - Ucraina 158
GB - Regno Unito 138
FI - Finlandia 89
FR - Francia 53
CZ - Repubblica Ceca 30
IN - India 24
VN - Vietnam 22
BE - Belgio 18
BR - Brasile 13
AT - Austria 11
EU - Europa 8
KR - Corea 8
CA - Canada 5
RU - Federazione Russa 5
AU - Australia 3
IL - Israele 3
NZ - Nuova Zelanda 3
CH - Svizzera 2
ES - Italia 2
HK - Hong Kong 2
NL - Olanda 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
IQ - Iraq 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 6.005
Città #
Chandler 659
Jacksonville 647
Dublin 617
Singapore 240
Boardman 221
Santa Clara 192
Izmir 133
Nanjing 121
Wilmington 115
San Mateo 99
New York 95
Lawrence 85
Princeton 85
Ashburn 82
Beijing 59
Ann Arbor 54
Dearborn 53
Nanchang 48
L'aquila 46
Milan 43
Shenyang 37
Brno 30
Verona 26
Mountain View 25
Seattle 25
Tianjin 25
Des Moines 22
Dong Ket 22
Falls Church 20
Helsinki 20
Munich 19
Bremen 17
Brussels 17
Hebei 17
Shanghai 15
Woodbridge 15
Philadelphia 14
Impruneta 13
Guangzhou 12
Jinan 11
Kunming 11
Los Angeles 11
Rome 11
Jiaxing 10
L’Aquila 10
Nuremberg 10
Dallas 9
Norwalk 9
Washington 9
Ningbo 8
Taizhou 8
Zhengzhou 8
Changsha 7
Pescara 7
Auburn Hills 6
Changchun 6
Hangzhou 6
Hefei 6
Kitzingen 6
Vienna 6
West Jordan 6
Frankfurt am Main 5
Pune 5
San Francisco 5
Cambridge 4
Houston 4
Lanzhou 4
Strasbourg 4
Toronto 4
Bologna 3
Catania 3
Düsseldorf 3
Fuzhou 3
Haikou 3
London 3
Pollenza 3
Redwood City 3
Trieste 3
Altidona 2
Aracaju 2
Auckland 2
Berlin 2
Borås 2
Cava de' Tirreni 2
Cedar Knolls 2
Central 2
Cesena 2
Chieti 2
Fairfield 2
Ferentino 2
Fremont 2
Johannesburg 2
Lanciano 2
Mumbai 2
Phoenix 2
Sora 2
Taiyuan 2
Tappahannock 2
Trestina 2
Almaty 1
Totale 4.371
Nome #
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 109
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 109
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. 106
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 106
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 104
The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells 102
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 92
Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es) 90
Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappa B elements 88
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in Neuroblastoma 85
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion 84
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 83
EGF- and cell-cycle-regulated STAG1/PMEPA1 ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer 82
All-trans-retinoic acid induces nuclear factor kappa B activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells 82
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity 82
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 79
Cis Golgi network-associated TrkAIII targets the interphase centrosome and promotes genetic instability 79
Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study 79
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 77
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 76
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 76
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 75
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 74
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 74
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. 74
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen 73
DIFFERENTIAL EXPRESSION OF TUMOR-CELL METALLOPROTEINASES AND TIMPS BY A PHORBOL ESTER 73
The effect of GRGDSP peptide, osteopontin and bone sialoprotein on metalloproteinases, tissue inhibitors of metalloproteinases, and plasminogen activators secreted by human osteoclastoma cells. 72
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 72
Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study 72
FOLLICLE-STIMULATING HORMONE INCREASES THE EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES TIMP-1 AND TIMP-2 AND INDUCES TIMP-1 AP-1 SITE BINDING COMPLEX(ES) IN PREPUBERTAL RAT SERTOLI CELLS 71
Mode of formation of synovial villi 71
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. 70
Alternative TrkA splicing and neuroblastoma 70
Multidisciplinary palliation for unresectable recurrent rectal cancer: Hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study 70
Increased chemiluminescence of polymorphonuclear leucocytes from patients with progressive systemic sclerosis 69
TrkAIII expression in the thymus 69
Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis 68
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target 68
BASEMENT-MEMBRANE TYPE-IV COLLAGEN DEGRADATION - EVIDENCE FOR THE INVOLVEMENT OF A PROTEOLYTIC CASCADE INDEPENDENT OF METALLOPROTEINASES 67
RAS LEVELS AND METALLOPROTEINASE ACTIVITY IN NORMAL VERSUS NEOPLASTIC RAT MAMMARY TISSUES 67
MAPPING OF RECEPTOR-BINDING SITES ON IL-1-BETA BY RECONSTRUCTION OF IL-1RA-LIKE DOMAINS 67
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. 67
Alternative TrkAIII splicing and Cancer 67
Characterisation of metastatic tumour cells 67
The transition from acute to chronic inflammation 66
STUDIES ON THE EFFECTS OF LAMININ, E-8 FRAGMENT OF LAMININ AND SYNTHETIC LAMININ PEPTIDES PA22-2 AND YIGSR ON MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASE EXPRESSION 66
REN: a novel, developmentally regulated gene that promotes neural cell differentiation 66
Opposing roles for specific TIMPs in breast cancer prognostic 65
IDENTIFICATION OF THE 72-KDA (MMP-2) AND 92-KDA (MMP-9) GELATINASE TYPE-IV COLLAGENASE IN PREPARATIONS OF LAMININ AND MATRIGEL(TM) 65
Identification of plasminogen in Matrigel(TM) and its activation by reconstitution of this basement membrane extract 65
Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease. 65
Effect of a lymphocyte-derived pro-inflammatory factor on carrageenan pleurisy in the rat 64
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 63
TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance 62
EXPRESSION OF 72 KD GELATINASE AND TYPE-IV COLLAGEN DURING CARBON TETRACHLORIDE-INDUCED RAT-LIVER FIBROSIS 61
Alternative TrkA splicing and Cancer 61
Studies into the mode of action of non-steroidal anti-inflammatory drugs using a model of facsimile synovium 60
Successful laparoscopic trans-peritoneal repair of an incisional inguinal hernia, resulting from deep lymph node dissection for melanoma: A case report 60
The interaction of leucocytes with vascular endothelial cells in vitro with respect to experimental inflammation in the rat 59
The effects of levan on the acute inflammatory response 59
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma 59
bcl-2 over-expression enhances NF-κB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells 58
Thioredoxin inhibits microvascular endothelial capillary tubule formation 58
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 58
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site 57
STUDIES ON THE ABILITY OF 65-KDA AND 92-KDA TUMOR-CELL GELATINASES TO DEGRADE TYPE-IV COLLAGEN 55
Enhancement of colloidal clearance in normal rats by sodium diethyl dithiocarbamate (DTC) 54
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 54
Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate 53
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: A pilot study 53
A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced WT BRAF Melanoma Patients 53
The alternative TrkAIII splice variant expressed by human neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 52
Effect of acute acupuncture on acute inflammation 52
Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival 52
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases 51
RETINOIC ACID-ENHANCED INVASION THROUGH RECONSTITUTED BASEMENT MEMBRANE BY HUMAN SK-N-SH NEUROBLASTOMA CELLS INVOLVES MEMBRANE-ASSACIATED TISSUE-TYPE PLASMINOGEN ACTIVATOR 51
Pyrrolopyrimidine class Src inhibitors inhibit osteoclast and bone metastatic tumor cell functions. 51
The alternative TRKAIII splice variant targets the centrosome and promotes genetic instability 50
Isolation and characterization of human natural killer cells 49
The role of plasma factors in the adherence of leucocytes to vascular endothelial cells 48
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 46
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer 46
Spontaneous metastasis of rat liver epithelial cells transformed with v-raf and v-raf/v-myc: association with different phenotypic properties 45
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 45
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 42
null 39
Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study 38
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 37
null 35
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 35
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 28
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells 24
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 19
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 17
Hypoxia-induced alternative TrkA splicing and reoxygenation-dependent TrkAIII activation: A cycling hypoxia-regulated resistance mechanism in neuroblastoma. 16
Studies on potentially druggable pathways that regulate stress-induced TrkAIII mitochondrial internalization, cleavage and activation in human neuroblastoma cells 14
Totale 6.158
Categoria #
all - tutte 27.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020513 0 0 0 0 0 105 158 28 96 32 11 83
2020/2021693 13 84 2 86 97 16 92 10 88 20 147 38
2021/2022503 35 41 59 23 40 13 13 34 28 11 40 166
2022/20231.812 125 115 39 191 172 206 3 102 775 11 40 33
2023/2024479 61 25 44 46 35 139 1 22 5 13 8 80
2024/2025759 50 35 166 102 241 165 0 0 0 0 0 0
Totale 6.158